journal article·2023-01-10

Opposites Attract: Electrostatically Driven Loading of Antimicrobial Peptides into Phytoglycogen Nanocarriers

Dalia A. Ali, Laura Domínguez Mercado, Brandon L. Findlay, Antonella Badia, Christine DeWolf

Langmuir· Volume 39· Issue 1
Publisher page

Abstract

Antimicrobial peptides, such as GL13K, have a high binding selectivity toward bacterial membranes, while not affecting healthy mammalian cells at therapeutic concentrations. However, delivery of these peptides is challenging since they are susceptible to proteolytic hydrolysis and exhibit poor cellular uptake. A protective nanocarrier is thus proposed to overcome these obstacles. We investigate the potential to employ biodegradable phytoglycogen nanoparticles as carriers for GL13K using a simple loading protocol based on electrostatic association rather than chemical conjugation, eliminating the need for control of chemical cleavage for release of the peptide in situ. Both the native (quasi-neutral) and carboxymethylated (anionic) phytoglycogen were evaluated for their colloidal stability, loading capacity, and release characteristics. We show that the anionic nanophytoglycogen carries a greater cationic GL13K load and exhibits slower release kinetics than native nanophytoglycogen. Isotope exchange measurements demonstrate that the antimicrobial peptide is entrapped in the pores of the dendritic-like macromolecule, which should provide the necessary protection for delivery. Importantly, the nanoformulations are active against a Pseudomonas aeruginosa clinical isolate at concentrations comparable to those of the free peptide and representative, small molecule antibiotics. The colloidal nanocarrier preserves peptide stability and antimicrobial activity, even after long periods of storage (at least 8 months).
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Antimicrobial Peptides and Activities · Polydiacetylene-based materials and applications · Bacteriophages and microbial interactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry and Biochemistry, Concordia University, Montreal, QuebecH4B 1R6, Canada

Centre for NanoScience Research, Concordia University, Montreal, QuebecH4B 1R6, Canada

FRQNT Centre Québécois sur les Matériaux Fonctionnels─Quebec Centre for Advanced Materials, McGill University, 845 Sherbrooke Street West, Montréal, QuebecH3A 0G4, Canada

Faculty of Pharmacy, Alexandria University, Alexandria5424041, Egypt

Département de Chimie, Université de Montréal, Complexe des sciences, C.P. 6128, succursale Centre-ville, Montréal, QuebecH3C 3J7, Canada

Funding

Fonds de Recherche du Qu?bec - Sant? · Fonds de Recherche du Qu?bec - Nature et Technologies · Concordia University · Natural Sciences and Engineering Research Council of Canada

References (75)

Show source-provided references
1. 10.1021/np200906s10.1021/np200906s ↗
2. 10.1111/cbdd.1205510.1111/cbdd.12055 ↗
3. 10.1517/14656566.2012.69277710.1517/14656566.2012.692777 ↗
4. 10.3389/fcimb.2016.0019410.3389/fcimb.2016.00194 ↗
5. 10.1007/s00251-007-0259-x10.1007/s00251-007-0259-x ↗
6. 10.2478/s11535-007-0010-510.2478/s11535-007-0010-5 ↗
7. 10.1016/j.biochi.2010.02.02310.1016/j.biochi.2010.02.023 ↗
8. 10.1080/13543776.2016.117614910.1080/13543776.2016.1176149 ↗
9. 10.1016/j.tibtech.2011.05.00110.1016/j.tibtech.2011.05.001 ↗
10. 10.1007/s00232-011-9343-010.1007/s00232-011-9343-0 ↗
11. 10.1002/cphc.20200002610.1002/cphc.202000026 ↗
12. 10.1016/j.bbamem.2008.09.01310.1016/j.bbamem.2008.09.013 ↗
13. 10.1124/pr.55.1.210.1124/pr.55.1.2 ↗
14. 10.1128/AAC.03937-1410.1128/AAC.03937-14 ↗
15. 10.1016/j.drudis.2016.10.01710.1016/j.drudis.2016.10.017 ↗
16. 10.1016/j.peptides.2012.03.01710.1016/j.peptides.2012.03.017 ↗
17. 10.1007/s11010-011-0991-210.1007/s11010-011-0991-2 ↗
18. 10.1128/AAC.00311-1310.1128/AAC.00311-13 ↗
19. Forum of International Respiratory Societies. The Global Impact of Respiratory Disease; European Respiratory Society: Lausanne, Switzerland, 2017; Vol. 2.
20. 10.1016/j.actbio.2013.06.01710.1016/j.actbio.2013.06.017 ↗
21. 10.1016/j.chembiol.2015.01.00210.1016/j.chembiol.2015.01.002 ↗
22. 10.1371/journal.pone.019490010.1371/journal.pone.0194900 ↗
23. 10.1016/j.ijpharm.2008.01.00810.1016/j.ijpharm.2008.01.008 ↗
24. 10.2147/IJN.S4819710.2147/IJN.S48197 ↗
25. 10.1515/biol-2018-003510.1515/biol-2018-0035 ↗
26. 10.1007/s40265-019-01095-z10.1007/s40265-019-01095-z ↗
27. 10.1002/wnan.158610.1002/wnan.1586 ↗
28. 10.1016/j.eurpolymj.2014.07.02510.1016/j.eurpolymj.2014.07.025 ↗
29. 10.1021/acs.bioconjchem.5b0031310.1021/acs.bioconjchem.5b00313 ↗
30. 10.3389/fphar.2021.60162610.3389/fphar.2021.601626 ↗
31. 10.1016/j.tifs.2020.11.01310.1016/j.tifs.2020.11.013 ↗
32. 10.1021/acs.biomac.5b0139310.1021/acs.biomac.5b01393 ↗
33. 10.1021/acs.langmuir.1c0190610.1021/acs.langmuir.1c01906 ↗
34. 10.1042/BST039102810.1042/BST0391028 ↗
35. Dutcher J. R. · Phys. Can. · 2017 · 73 · 91
36. 10.1016/j.carbpol.2019.11509510.1016/j.carbpol.2019.115095 ↗
37. 10.1016/j.ijpharm.2017.11.00410.1016/j.ijpharm.2017.11.004 ↗
38. 10.1016/j.carbpol.2017.10.00410.1016/j.carbpol.2017.10.004 ↗
39. 10.1016/j.xphs.2018.12.02610.1016/j.xphs.2018.12.026 ↗
40. 10.1016/j.ejpb.2021.07.01710.1016/j.ejpb.2021.07.017 ↗
41. 10.1038/s41598-019-49931-210.1038/s41598-019-49931-2 ↗
42. 10.1038/s41541-017-0007-710.1038/s41541-017-0007-7 ↗
43. 10.1016/j.foodchem.2016.10.06410.1016/j.foodchem.2016.10.064 ↗
44. 10.1016/j.foodres.2017.04.02110.1016/j.foodres.2017.04.021 ↗
45. 10.1016/j.jconrel.2010.11.02410.1016/j.jconrel.2010.11.024 ↗
46. 10.1002/bit.2309910.1002/bit.23099 ↗
47. 10.1016/j.jconrel.2003.12.02010.1016/j.jconrel.2003.12.020 ↗
48. 10.1016/j.biomaterials.2007.12.03810.1016/j.biomaterials.2007.12.038 ↗
49. 10.1093/jac/dkz28410.1093/jac/dkz284 ↗
50. 10.1016/j.foodhyd.2019.10539010.1016/j.foodhyd.2019.105390 ↗
51. 10.1016/S0378-5173(03)00225-410.1016/S0378-5173(03)00225-4 ↗
52. 10.1039/C6RA06003J10.1039/C6RA06003J ↗
53. 10.1016/j.xphs.2018.08.02310.1016/j.xphs.2018.08.023 ↗
54. 10.1038/nprot.2007.52110.1038/nprot.2007.521 ↗
55. 10.1002/1521-379X(200011)52:11<413::AID-STAR413>3.0.CO;2-B10.1002/1521-379X(200011)52:11<413::AID-STAR413>3.0.CO;2-B ↗
56. 10.1111/j.1747-0285.2008.00661.x10.1111/j.1747-0285.2008.00661.x ↗
57. 10.1186/1758-2946-6-S1-P3510.1186/1758-2946-6-S1-P35 ↗
58. 10.1016/j.bbamem.2013.05.02710.1016/j.bbamem.2013.05.027 ↗
59. 10.1002/bkcs.1209810.1002/bkcs.12098 ↗
60. 10.1016/0079-6816(93)90013-L10.1016/0079-6816(93)90013-L ↗
61. 10.1021/j150453a00110.1021/j150453a001 ↗
62. 10.1021/acs.langmuir.7b0002510.1021/acs.langmuir.7b00025 ↗
63. Khalane L. · Terminology · 2016 · 4 · 5
64. Bhowmik D. · Pharma Innov. · 2012 · 1 · 24
65. 10.1016/j.carbpol.2015.03.05810.1016/j.carbpol.2015.03.058 ↗
66. 10.3390/pharmaceutics1204038710.3390/pharmaceutics12040387 ↗
67. 10.1002/jps.2170610.1002/jps.21706 ↗
68. 10.1063/1.173099910.1063/1.1730999 ↗
69. 10.1016/j.carbpol.2013.12.07810.1016/j.carbpol.2013.12.078 ↗
70. 10.1021/acs.biomac.5b0050010.1021/acs.biomac.5b00500 ↗
71. 10.1007/978-1-62703-275-9_910.1007/978-1-62703-275-9_9 ↗
72. 10.1021/acschembio.9b0003210.1021/acschembio.9b00032 ↗
73. 10.1021/acs.biochem.7b0052610.1021/acs.biochem.7b00526 ↗
74. 10.3389/fimmu.2018.0241610.3389/fimmu.2018.02416 ↗
75. 10.1093/jac/dkz28310.1093/jac/dkz283 ↗